596
Participants
Start Date
September 30, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
April 30, 2011
1.2% Sodium Hyaluronate
IA-BioHA is supplied in a disposable 7 ml nominal volume glass syringe containing 60 mg/5 ml of 1.2% sodium hyaluronate. Participants are given a single injection in the target knee on Day 1 of the double-blind period and optionally on the first day of the open-label period (approximately week 27).
Buffered Saline
IA-SA is supplied in a disposable 7 ml nominal volume glass syringe containing 5 ml of phosphate buffered saline. Participants are given a single injection in the target knee on Day 1 of the double-blind period.
Apex Clinical Trials, LLC, Homewood
Tucson Orthopaedic Institute, Tucson
St. Joseph's Mercy Clinic, Hot Springs
Rx Medical Research of Arkansas, Inc, Little Rock
Southbay Pharma Research, Buena Park
Providence Clinical Research, Burbank
Triwest Research Associates, La Mesa
UCLA-Division of Rheumatology, Los Angeles
Investigational Site, Santa Barbara
Colorado Arthritis Center, PC, Englewood
Front Range Clinical Research, Wheat Ridge
New England Research Associates, LLC, Trumball
International Physicians Research, Aventura
Investigational Site, Fort Lauderdale
Sunrise Medical Research, Lauderdale Lakes
Tri-County Orthopaedic Center, Leesburg
Clinical Research Center LLC, Wellington
National Pain Research Institute, LLC, Winter Park
Georgia Institute for Clinical Research, Marietta
Pinnacle Orthopaedics and Sports Medicine, Marietta
Lee Research Institute, Shawnee
Professional Research Network of Kansas, Wichita
New Jersey Physicians, LLC, Passaic
Research Department, Bone & Joint Hospital at St. Anthony, Oklahoma City
Omega Medical Research, Warwick
Palmetto Medical Research, Mt. Pleasant
Palmetto Clinical Trial Services, LLC, Simpsonville
Black Hills Orthopedic & Spine Center, Rapid City
Holston Medical Group, Kingsport
McKenzie Medical Center, McKenzie
Texas Orthopedic Specialists, PA, Grapevine
Memorial Bone & Joint Research Foundation, Houston
Discovery Clinical Trials (DCT) - Stone Oak, LLC, San Antonio
Northwest Clinical Research Center, Bellevue
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY